Abstract
Background: Pure Red Cell Aplasia (PRCA) is a clinical entity comprising severe normochromic normocytic anemia, reticulocytopenia, erythroblastopenia in the bone marrow, with normal leukocyte and platelets count. PRCA can be classified into congenital and acquired, with the latter characterized as idiopathic or secondary to various infections, hematological malignancies, collagen vascular diseases, thymoma, and exposure to a variety of drugs and other chemical substances.
Methods: Herein, we present a female patient, who presented with PRCA due to azathioprine treatment.
Results: Prompt discontinuation of the drug together with red blood cells transfusions led to complete recovery in this young patient, without any addition of immunosuppressive regimen.
Conclusion: We followed ‘the wait and see practice’ instead of administering immunosuppression to our patient, after careful consideration and extensive consultation with our hematologists. This ‘wait and see practice’ proved to be effective in the long run.
Keywords: Azathioprine, pure red cell aplasia, adverse effect, malignancies, anemia, collagen vascular diseases.
Graphical Abstract
[http://dx.doi.org/10.1182/blood-2016-05-717140] [PMID: 27881371]
[http://dx.doi.org/10.1007/s00277-013-1779-0] [PMID: 23680868]
[http://dx.doi.org/10.1136/gut.34.8.1081] [PMID: 8174958]
Cardiovascular & Hematological Disorders-Drug Targets
Title:Pure Red Cell Aplasia Caused by Azathioprine
Volume: 20 Issue: 2
Author(s): Dimitris Kounatidis, Natalia Vallianou*, Vasiliki Daskalaki, Christos Masaoutis, Evangelia Margellou, Nikos Harhalakis and Evangelos Kokkinakis
Affiliation:
- Evangelismos General Hospital, Athens,Greece
Keywords: Azathioprine, pure red cell aplasia, adverse effect, malignancies, anemia, collagen vascular diseases.
Abstract:
Background: Pure Red Cell Aplasia (PRCA) is a clinical entity comprising severe normochromic normocytic anemia, reticulocytopenia, erythroblastopenia in the bone marrow, with normal leukocyte and platelets count. PRCA can be classified into congenital and acquired, with the latter characterized as idiopathic or secondary to various infections, hematological malignancies, collagen vascular diseases, thymoma, and exposure to a variety of drugs and other chemical substances.
Methods: Herein, we present a female patient, who presented with PRCA due to azathioprine treatment.
Results: Prompt discontinuation of the drug together with red blood cells transfusions led to complete recovery in this young patient, without any addition of immunosuppressive regimen.
Conclusion: We followed ‘the wait and see practice’ instead of administering immunosuppression to our patient, after careful consideration and extensive consultation with our hematologists. This ‘wait and see practice’ proved to be effective in the long run.
Export Options
About this article
Cite this article as:
Kounatidis Dimitris, Vallianou Natalia *, Daskalaki Vasiliki , Masaoutis Christos, Margellou Evangelia , Harhalakis Nikos and Kokkinakis Evangelos , Pure Red Cell Aplasia Caused by Azathioprine, Cardiovascular & Hematological Disorders-Drug Targets 2020; 20 (2) . https://dx.doi.org/10.2174/1871529X18666180828145818
DOI https://dx.doi.org/10.2174/1871529X18666180828145818 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets Sirtuin Inhibitors: An Overview from Medicinal Chemistry Perspective
Anti-Cancer Agents in Medicinal Chemistry Bone Seeking Radiopharmaceuticals for Palliation of Pain in Cancer Patients with Osseous Metastases
Anti-Cancer Agents in Medicinal Chemistry STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
Current Medicinal Chemistry Growth Factor Signaling and Resistance to Cancer Chemotherapy
Current Topics in Medicinal Chemistry Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
Current Cancer Drug Targets Targeting Transcription Factor Binding to DNA by Competing with DNA Binders as an Approach for Controlling Gene Expression
Current Topics in Medicinal Chemistry Induction of Thyroid Neoplasm Following Plant Medicine Marine Algae (Sargassum): A Rare Case and Review of the Literature
Current Pharmaceutical Biotechnology Epigenetics in Clinical Management of Children and Adolescents with Brain Tumors
Current Cancer Drug Targets The Hedgehog Knows Many Tricks
Current Drug Targets in vitro Anti-leukaemia Activity of Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs)
Recent Patents on Anti-Cancer Drug Discovery Targeting the Tumor Stroma with Peroxisome Proliferator Activated Receptor (PPAR) Agonists
Anti-Cancer Agents in Medicinal Chemistry System Models, Assays and Endpoint Parameters to Evaluate Anticancer Compounds During Preclinical Screening
Current Medicinal Chemistry Current Status and Future Prospects of C1 Domain Ligands as Drug Candidates
Current Topics in Medicinal Chemistry Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance
Current Pharmaceutical Design Biosafety of Adenoviral Vectors
Current Gene Therapy Metabolism of the Novel IMP Dehydrogenase Inhibitor Benzamide Riboside
Medicinal Chemistry Reviews - Online (Discontinued) Arylurea Derivatives: A Class of Potential Cancer Targeting Agents
Current Topics in Medicinal Chemistry Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry Recent Advances of Kinesin Motor Inhibitors and their Clinical Progress
Reviews on Recent Clinical Trials